Related references
Note: Only part of the references are listed.Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT
Justin L. Grodin et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients
Cho-Kai Wu et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Treatment of Heart Failure With Preserved Ejection Fraction Reflections on Its Treatment With an Aldosterone Antagonist
Marc A. Pfeffer et al.
JAMA CARDIOLOGY (2016)
Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study
Pardeep S. Jhund et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices
Cho-Kai Wu et al.
SCIENTIFIC REPORTS (2015)
Prognostic Value of Estimated Plasma Volume in Heart Failure
Kevin Duarte et al.
JACC-HEART FAILURE (2015)
Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
Selma F. Mohammed et al.
CIRCULATION (2015)
Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan Diastolic Heart Failure Registry and molecular basis by cellular and animal models
Cho-Kai Wu et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Decongestion in acute heart failure
Robert J. Mentz et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
Feng Liu et al.
PLOS ONE (2014)
Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart Failure
Robb D. Kociol et al.
CIRCULATION-HEART FAILURE (2013)
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial
Stephen J. Greene et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Timing of Hemoconcentration During Treatment of Acute Decompensated Heart Failure and Subsequent Survival Importance of Sustained Decongestion
Jeffrey M. Testani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients Presenting With Acute Decompensated Heart Failure
Peter van der Meer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction Prevalence, Therapies, and Outcomes
Benjamin A. Steinberg et al.
CIRCULATION (2012)
Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction Findings From the I-PRESERVE Trial
Inder S. Anand et al.
CIRCULATION-HEART FAILURE (2011)
Plasma levels of tumor necrosis factor-α and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase
Cho-Kai Wu et al.
CRITICAL CARE MEDICINE (2011)
Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival
Jeffrey M. Testani et al.
CIRCULATION (2010)
How to diagnose diastolic heart failure:: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Walter J. Paulus et al.
EUROPEAN HEART JOURNAL (2007)
Serial testing of B-type natriuretic pepticle and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of results
Alan H. B. Wu
AMERICAN HEART JOURNAL (2006)
B-type natriuretic peptide for acute dyspnea in patients with kidney disease: Insights from a randomized comparison
C Mueller et al.
KIDNEY INTERNATIONAL (2005)
Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): Rationale and design
GC Fonarow et al.
AMERICAN HEART JOURNAL (2004)
Obesity and suppressed B-type natriuretic peptide levels in heart failure
MR Mehra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
The regulation and measurement of plasma volume in heart failure
PR Kalra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure
G Marenzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
A survey on the quality of care among patients with heart failure in Europe
JGF Cleland et al.
EUROPEAN JOURNAL OF HEART FAILURE (2000)
Share Paper
